» Authors » Dick Oepkes

Dick Oepkes

Explore the profile of Dick Oepkes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 224
Citations 1845
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Vos T, Tersteeg I, Lopriore E, Oepkes D, Porcelijn L, van der Schoot C, et al.
Vox Sang . 2024 Dec; 120(2):178-187. PMID: 39638612
Background And Objectives: Foetal and neonatal alloimmune thrombocytopenia (FNAIT) results from maternal platelet-directed antibodies and can result in severe intracranial haemorrhage (ICH) in foetuses and newborns. Screening for human platelet...
2.
Kariman S, van den Heuvel J, Adriaanse B, Oepkes D, Bekker M
Prenat Diagn . 2024 Oct; PMID: 39390612
Objective: To explore the use of tele-ultrasound and handheld or self-operated ultrasound in pregnancy. Methods: A systematic search provided 31 studies. The risk of bias for each study was assessed....
3.
Komatsu Y, Verweij E, Tiblad E, Lopriore E, Oepkes D, Agarwal P, et al.
Am J Perinatol . 2024 Aug; PMID: 39197469
Objective:  Nipocalimab is a neonatal fragment crystallizable (Fc) receptor (FcRn)-blocking monoclonal antibody that inhibits placental immunoglobulin G (IgG) transfer and lowers circulating maternal IgG levels. In an open-label, single-arm, phase...
4.
Moise Jr K, Ling L, Oepkes D, Tiblad E, Verweij E, Lopriore E, et al.
N Engl J Med . 2024 Aug; 391(6):526-537. PMID: 39115062
Background: In early-onset severe hemolytic disease of the fetus and newborn (HDFN), transplacental transfer of maternal antierythrocyte IgG alloantibodies causes fetal anemia that leads to the use of high-risk intrauterine...
5.
Sagar R, Astrom E, Chitty L, Crowe B, David A, DeVile C, et al.
BMJ Open . 2024 Jun; 14(6):e079767. PMID: 38834319
Introduction: Severe osteogenesis imperfecta (OI) is a debilitating disease with no cure or sufficiently effective treatment. Mesenchymal stem cells (MSCs) have good safety profile, show promising effects and can form...
6.
Zwiers C, Slootweg Y, Koelewijn J, Ligthart P, van der Bom J, van Kamp I, et al.
Vox Sang . 2024 May; 119(8):859-866. PMID: 38772910
Background And Objectives: To evaluate the severity of haemolytic disease of the foetus and newborn (HDFN) in subsequent pregnancies with RhD immunization and to identify predictive factors for severe disease....
7.
de Vos T, Winkelhorst D, Porcelijn L, Beaufort M, Oldert G, van der Bom J, et al.
Lancet Haematol . 2024 Feb; 10(12):e985-e993. PMID: 38407610
Background: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare disease that untreated can lead to intracranial haemorrhage or death. The natural history of FNAIT is still unclear; therefore, the...
8.
Ree I, de Haas M, van Geloven N, Juul S, de Winter D, Verweij E, et al.
Lancet Haematol . 2023 Nov; 10(12):e976-e984. PMID: 38030319
Background: Up to 88% of infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions require erythrocyte transfusions after birth. We aimed to investigate the...
9.
de Winter D, Kaminski A, Tjoa M, Oepkes D, Lopriore E
BMC Pregnancy Childbirth . 2023 Oct; 23(1):738. PMID: 37853331
Background: Advances in postnatal care for hemolytic disease of the fetus and newborn (HDFN) have occurred over the past decades, but little is known regarding the frequency of postnatal treatment...
10.
Vant Oever R, Zwiers C, de Haas M, le Cessie S, Lopriore E, Oepkes D, et al.
BJOG . 2023 Sep; 131(6):769-776. PMID: 37743689
Objective: Pregnant women who received at least one intrauterine transfusion (IUT) for haemolytic disease of the fetus and newborn (HDFN) in the preceding pregnancy are presumed to have a high...